Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer

NCT00003520 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

15

Enrollment

OTHER

Sponsor class

Stopped slow accrual

Conditions

Stage IV Kidney Cancer

Interventions

DRUG: Antineoplaston therapy (Atengenal + Astugenal)

Sponsor

Burzynski Research Institute